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ttp://dx.doi.org/10.1016/j.ajpath.2012.11.021Intestinal ischemia has a wide variety of causes, including, but not limited to, atherosclerosis,
thrombosis, hypotension, and chronic inﬂammation. In severe cases, ischemic injury can result in
death. m-Opioid receptor (MOR) signaling has previously been shown to protect against chemically
induced colitis, but the cellular origin of this effect remains unknown. Herein, we evaluated the role
of intestinal epithelial cell (IEC)ederived MOR signaling in host responses to ischemia/reperfusion-
induced injury. Ileal ischemia was accomplished through obstruction of the distal branches of the
superior mesenteric artery (60 minutes) and reperfusion for 90 minutes (ischemia-reperfusion).
Floxed-MOR mice were crossed to Villin-cre transgenic mice to selectively delete the MOR gene in IECs
(MORIEC/). Radio-ligand binding assays demonstrated selective loss of MOR signaling in IECs of
MOR IEC/ mice. The s.c. administration of the MOR agonist, [D-Arg2, Lys4] dermorphin (1e4) amide
(DALDA), 10 minutes before surgery protected against both ischemic and reperfusion phases of
intestinal injury, an effect abolished in MOR IEC/ mice. This cytoprotective effect was associated
with enterocyte-mediated phosphoinositide 3-kinase (PI3K)/glycogen synthase kinase 3b signaling
and decreased apoptosis, as determined by IHC and caspase-3 processing. PI3K blockade with
Ly294002 resulted in loss of MOR-mediated cytoprotective function. Together, these data show
that IEC-derived m-opioid signaling uses the PI3K pathway to protect cells against the damaging
effect of ischemia-reperfusion. Targeting MOR signaling may represent a novel mean to alleviate
intestinal injury and promote the wound-healing response. (Am J Pathol 2013, 182: 776e785;
http://dx.doi.org/10.1016/j.ajpath.2012.11.021)Supported by NIH grants R01DK047700 (C.J.), R01DK073338 (C.J.), and
F30DK085906 (J.R.G.) and an NIH contract 271200800025C-6-0-1 (B.R.).
J.R.G. and E.P.-C. contributed equally to this work.The gastrointestinal epithelium performs a wide array of
functions for the host, including secretion/absorption of
nutrients, innate immune surveillance, and a physical barrier
against the rich, diverse, and potentially immunogenic
luminal contents. Therefore, preserving the integrity and
maintaining intestinal barrier function are critical for host
homeostasis. At the forefront of the intestinal barrier lies
a singlemonolayer of intestinal epithelial cells (IECs),1 which
form a tight network of cells through the formation of tight
junctions between IECs. These tight junctions are a critical
component of the epithelium, and are necessary for the
maintenance of the barrier during epithelial injury.2,3 The
epithelium is a dynamic system with highly migratory andstigative Pathology.
.proliferative IECs that help maintain and replace the barrier.3
These active cells require constant high levels of blood ﬂow to
maintain their function. The superior mesenteric artery
supplies blood to the small intestine and proximal two thirds
of the large bowel, whereas the inferior mesenteric artery
supplies the last third of the colon.4e6 These arteries are
supplemented by signiﬁcant collateral blood ﬂow to ensure
proper intestinal function.4e6
Various events, such as chronic inﬂammation,7 infec-
tion,1 medications,8,9 and ischemia, can all result in the loss
Figure 1 Generation of IEC-speciﬁc, MOR geneedeleted mice. A:
Schematic representation of the exon-ﬂanked loxP sites of MORf/f mice. B:
Real-time PCR analysis of MOR (oprm1) mRNA accumulation from IECs and
splenocytes obtained from MORf/f and MORIEC/ mice. Villin and CD45 are
used as marker of enterocytes and immune cells, respectively. Gapdh is used
as a loading control. Biological duplicates are shown.
IEC-MOR Signaling in Intestinal Injuryof the intestinal barrier,4,10 with deleterious consequences
for the host. Among these various conditions, intestinal
ischemia has been associated with severe disruption of
small intestinal barrier function and integrity. Intestinal
ischemia results in tissue hypoxia, which can cause
induction of cellular apoptosis and loss of the protective
epithelial layer. In addition to ischemia, the intestine can
experience various levels of hypoxia because of athero-
sclerotic blockade, hemorrhage, venous emboli, surgical
clamping, and cardiac tamponade.10 In all of these cases,
enteric blood supply must be reduced by at least 50% to
overcome compensatory mechanisms.4 Paradoxically, the
restoration of blood ﬂood (reperfusion) enhances the
damage to the intestine through the introduction of oxygen
free radicals and increased immune cell activation.10 In
severe cases, ischemia/reperfusion (I/R) injury can result in
multiple organ dysfunction syndrome, with a mortality rate
of approximately 30%.11
I/R-induced injury occurs in a multistep manner. In the
ﬁrst phase, the impaired blood ﬂow to the epithelium gen-
erates an adaptive response involving the activation of
protective signaling events that induce activity of different
transcription factors, such as hypoxia-inducible factor12 and
NF-kB.13 In the second phase, the adaptive response is
generally overwhelmed by the rapid re-introduction of blood
ﬂow/oxygen (reperfusion), which enhances and sustains the
inﬂammatory response.10 Finally, the sustained intestinal
immune response compromises the intestinal barrier function
of the epithelium, allowing bacterial translocation across the
mucosa, leading to bacteremia and sepsis, and generating
a positive feedback loop of inﬂammation and intestinal
damage.10
Unfortunately, current treatment of I/R injury is com-
pletely supportive, and no treatments focus on restoring the
epithelial barrier defects that can lead to multiple organ
dysfunction syndrome. Recently, we found that MOR
signaling is protective against chemical-induced acute in-
testinal injury.14 Rodent studies have demonstrated that
opioids, such as morphine, are cardioprotective during
ischemic episodes,15,16 and these observations have been
successfully extended to a randomized, double-blind, clin-
ical trial.17 MOR is a G proteinecoupled receptor, and the
cardioprotective effects of MOR signaling are believed to
act through the Gbg subunit of the Gi protein coupled to
MOR. Speciﬁcally, the Gbg subunit activates phosphoino-
sitide 3-kinase (PI3K),18 which can result in numerous
prosurvival downstream signaling events, predominately
mediated through Akt activation.19 However, the role and
cellular source of MOR signaling during I/R-mediated in-
testinal injury remain to be deﬁned.
In these studies, we establish that MOR signaling is
protective against both the ischemic and reperfusion phases of
intestinal I/R-induced injury. Genetic approaches show that
IEC-speciﬁc MOR signaling is the source of the cytopro-
tective responses. The MOR-mediated protective effect was,
in part, attributed to PI3K signaling because pharmacologicalThe American Journal of Pathology - ajp.amjpathol.orginhibition of the pathway abrogated the DALDA-induced
beneﬁcial impact.Materials and Methods
Generation of MORIEC/ Mice
All mice were on the C57BL/6 background. Villin-Cre mice
were crossed to MORf/f mice, which contain loxP sites in
introns 1 and 3, to generate mice lacking exons 2 and 3 of the
MOR (Figure 1A). MORf/f mice were generated by Xenogen
Biosciences (Hopkinton, MA) using homologous recombina-
tion. Tail snips were collected from all pups generated from
crosses, and genomic DNAwas isolated using a Qiagen Blood
and Tissue Kit (Qiagen, Valencia, CA). Mice were bred to
generate the homozygoteMORf/f allele and theVillin-Cregene.
Primers used for genotyping were as follows: Villin-Cre pro-
moter (50-TAAGAAAGGATCATCATCAAAGCCGG-30 and
50-GTGAAACAGCATTGCTGTCACTT-30) andFlox-Oprm1
(50-GTGTTTAAACATAGGTACAAGATATTCCCAAGCG-
AGA-30 and 50-GTCTCGAGCTGAGATTTAGGAAAGGT-
GTCGAATTATTG-30).
For phenotypic analysis, RNA was isolated from enter-
ocytes and splenocytes as previously described,20 and
expression of MOR, Oprm1, and Gapdh was determined by
RT-PCR. Amplicons were resolved on a 2% agarose gel and
visualized using a Kodak Gel Logic Imager 200 series
(Kodak, Rochester, NY). Primers used were as follows:
Oprm1 (amplicon, 569 bp; 50-ACCTGGCTCCTGGCTCA-
ACT-30 and 50- TGGACCCCTGCCTGTATTTTG-30), Vil-
lin1 (amplicon, 330 bp; 50-CCCCCATCTTCCA-30 and
50-TGCCCTGCCAGATATATAACA-30), CD45 (Ptprc)
(amplicon, 70 bp; 50-ATGGTCCTCTGAATAAAGCCCA-30
and 50-TCAGCACTATTGGTAGGCTCC-30), Gapdh (ampli-
con, 240 bp; 50-GGTGAAGGTCGGAGTCAACGGA-30 and
50-GAGGGATCTCGCTCCTGGAAGA-30).21777
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MORf/f and MORIEC/ mice (C57BL/6 background) were
maintained in standard housing cages in speciﬁc pathogen-
free conditions. Mice (n Z 4 to 6) were anesthetized under
1% isoﬂurane, supplemented by 10 mg/kg ketamine injected
s.c. Vehicle (saline) or the MOR agonist, DALDA22 (100%
saline, 50 mg/kg) (US Biological, Swampscott, MA), was
injected s.c. 10 minutes before surgery. The PI3K inhib-
itor, Ly294002 (0.25 mg/kg) (Calbiochem, Darmstadt,
Germany), was injected i.p. 10 minutes before the admin-
istration of DALDA. A midline laparotomy was made, and
peripheral branches of superior mesenteric artery were
occluded with aneurysm clips (Kent Scientiﬁc, Torrington,
CT), to generate a 2- to 3-cm region of ischemic ileum
adjacent to the cecum. Collateral blood ﬂow through the
intestine was blocked using aneurysm clips across the
intestine and collateral vessels, demarking the region of
ischemic intestine. Hematoxylin was administered to the
edges of ischemic tissue to mark them, and then the incision
was closed with surgical staples. Ischemia was maintained
for 60 minutes, and then the incision was re-opened, the
clamps were removed, and the incision was reclosed. The
mice were maintained in a heated room for a variable
amount of time (0, 1.5, or 4 hours) without anesthesia for
the reperfusion phase of injury. All animal experiments
were approved by the Institutional Animal Care and Use
Committee of the University of North Carolina, Chapel Hill
(Chapel Hill, NC).
Murine Sample Collection and Histological Evaluation
Mice were anesthetized using isoﬂurane, and then sacriﬁced
by cervical dislocation. The colon was dissected and ﬂushed
with ice-cold PBS, longitudinally splayed, Swiss rolled,
ﬁxed in 10% formalin for 24 hours, and then embedded in
parafﬁn. Damage severity was evaluated using H&E-stained
sections by blinded investigators (J.R.G., E.P.C.). The
scoring system is based on an IEC apoptosis/necrosis
system,23 where a score of 1 signiﬁed a loss of only the
villus tips; 2, loss of 50% of the villus; 3, a loss of the entire
villus, but with maintenance of the crypt; and 4, complete
loss of the epithelial layer. Fractional (to the nearest 0.5)
scores were given, and the score was based on the average
damage of the entire tissue section.
Cell Membrane Fraction Isolations
Primary IECs were isolated as previously described.24
Brieﬂy, small intestines and colons were opened longitudi-
nally and washed, and IECs were separated from the under-
lining tissue by shaking the intestines in a solution containing
1.5 mmol/L EDTA (with 0.5 mmol/L dithiothreitol for colon
sections) and proteinase inhibitors (Complete Mini; Roche
Diagnostics GmbH, Penzberg, Germany) for 30 minutes at
37C. The remaining tissue was ﬁltered with a 0.45-mm cell778culture ﬁlter to remove the underlying stroma, and samples
from three mice were pooled and spun at 1000  g for
5 minutes. Cells were lysed in chilled, hypotonic 50 mmol/L
Tris-HCl, pH 7.4, solution for 30 minutes. Cell membrane
isolates were then prepared by washing the lysate three times
in standard binding buffer [50 mmol/L Tris-HCl, 10 mmol/L
MgCl2, and 0.1 mmol/L EDTA (pH 7.4)], followed by cen-
trifugation at 21,000 g. The lysate was then resuspended in
the binding buffer and passaged through a 26-gauge needle
to ensure homogenization, forming the ﬁnal membrane sus-
pensions used in the radioligand binding assays.
Brain membrane homogenates were made using cortex
tissue. Brains were harvested from mice, and their cortices
were dissected. The tissues were homogenized in standard
binding buffer with proteinase inhibitors using a polytron
(IKA Works Inc., Wilmington, NC), and then prepared in
the same manner as the IECs in standard binding buffer. The
protein concentration of each membrane suspension was
determined by using a Bio-Rad quantiﬁcation assay (Bio-
Rad Laboratories, Hercules, CA).
Radioligand Binding Assay
Radioligand binding assays were performed by the Psycho-
active Drug Screening Program at the University of North
Carolina, Chapel Hill, using a modiﬁcation of previously
described procedures.25Membrane suspensions (50 mL) were
incubated with 0.3, 0.6, 1.25, 2.5, 5, or 10 nmol/L
H3-[D-Ala2, N-MePhe4, Gly-ol]-enkephalin (DAMGO) (GE
Healthcare, Piscataway, NJ), with or without 10 mmol/L
naltrexone (Sigma-Aldrich, St. Louis, MO), for 1 hour at
room temperature, shielded from light. Samples were then
harvested by rapid ﬁltration onto Whatman GF/B glass ﬁber
ﬁlters presoaked with 0.3% polyethyleneimine using
a 96-well Brandel harvester. Four rapid 500-mL washes were
performedwith chilled standard binding buffer to reduce non-
speciﬁc binding. The ﬁlter mats were dried, scintillant was
melted onto the ﬁlters, and the radioactivity was counted
using a Microbeta scintillation counter. Radioactivity of
H3-DAMGO was quantiﬁed by liquid scintillation counting,
using EcoScint scintillation cocktail (National Diagnostics,
Atlanta, GA). Rawdata (decays perminute) were converted to
fmols of ligand binding/mg of total tissue, using a detection
efﬁciency of 0.5 to convert from decays per minute to counts
per minute.
IHC and Immunoﬂuorescence
Immunohistochemical (IHC) staining was performed ac-
cording to the manufacturer’s speciﬁcations, as previously
described.20 Primary antibodies and dilutions were as follows:
glycogen synthase kinase 3b (p-GSK3b; Ser9), 1:400 (Cell
Signaling Technology, Beverly, MA); and p-AKT (Ser473),
1:50 (Cell Signaling Technology). IHC for activated caspase-
3, 1:400 (R&D Systems, Minneapolis, MN) was performed
as previously described.26 All sections were counterstainedajp.amjpathol.org - The American Journal of Pathology
Table 1 MORIEC/ Enterocytes Do Not Bind m Ligand
Mouse strain
DAMGO Bmax
Cortex, nmol/L Enterocyte, nmol/L
MORf/f 165.6  16.10 11.55  4.397
MORIEC/ 108.5  13.10 No binding detected
Data are given as fmol/mg. Radioligand binding assays using the MOR-
speciﬁc agonist H3-DAMGO demonstrated an absence of intestinal
binding in MORIEC/ mice. No statistically signiﬁcant difference between
MORf/f and MOR IEC/ binding was observed (P Z 0.0705) in the cortex
(brain) samples used as a positive control. N Z 4 or 6 per group.
IEC-MOR Signaling in Intestinal Injurywith hematoxylin. Only crypts that had two or more positively
staining cells per 10 total crypts in a ﬁeld of viewwere counted
for IHC analysis.
A ﬂuorometric TUNEL assay was performed using a
DeadEnd Kit (Promega, Madison, WI), according to the
manufacturer’s protocols. Images were acquired using a Zeiss
710 microscope with a 20, 1.4 numerical aperture objective
(Carl Zeiss, Thornwood, NY). Zeiss Zen 2009 software (Carl
Zeiss) was used for image acquisition. All images were
acquired at room temperature.
RNA Isolation and Real-Time PCR
RNA isolation from ileal tissues and subsequent cDNA ampli-
ﬁcation and analysis were performed as previously described,20
using an ABI Prism HT7700 (Applied Biosystems, Foster City,
CA). The speciﬁcity and linearity of ampliﬁcation for each
primer set were determined by melting curve analysis andThe American Journal of Pathology - ajp.amjpathol.orgcalculation of the slope fromserial diluted samples.Relative fold
changes were determined using the DDCT calculation method.
Valueswere normalized to the internal control, glyceraldehyde-
3-phosphate dehydrogenase (GAPDH)orb-actin. Primerswere
as follows: Il6 (50-CGGAGGCTTAATTACACATGTT-30 and
50-CTGGCTTTGTCTTTCTTGTTATC-30),21 Il1b (50-GCC-
CATCCTCTGTGACTCAT-30 and 50-AGGCCACAGGTA-
TTTTGTCG-30),14Gapdh (50-GGTGAAGGTCGGAGTCAA-
CGGA-30 and 50-GAGGGATCTCGCTCCTGGAAGA-30),21
and b-actin (50-TTACCAACTGGGACGACATG-30 and
50CTGGGGTGTTGAAGGTCTC-30).
Bacterial Ribosomal 16S DNA
For all bacterial translocation assays,micewere subjected to 60
minutes of ischemia, followed by 4 hours of reperfusion, in the
presence or absence ofDALDA, as previously described.Mice
were sacriﬁced, and their livers were harvested and weighed.
To determine bacterial 16S ribosomal DNA (rDNA) loads,
livers were incubated in lysis buffer [200 mmol/L NaCl, 100
mmol/L Tris-HCl (pH 8), 20 mmol/L EDTA, and 20 mg/mL
lysozyme] for 30 minutes at 37C, and then in 1% SDS and
0.35 mg/mL proteinase K (Sigma-Aldrich) for 30 minutes at
60C. The homogenates were further lysed in a 60% volume of
phenol/chloroform/isoamyl alcohol mixture (25:24:1) using
a Mini Bead Beater 8 (Biospec, Bartleville, OK). DNA was
isolated using a chloroform/isoamyl alcohol (24:1) solution
and precipitated with 2.5 volumes of ethanol with 3 mol/L
sodium acetate (pH 5.2) overnight at 20C. The pellet was
resuspended in Tris buffer (10 mmol/L, pH 8), and a QiagenFigure 2 DALDA (DAL) administration protects
against I/R-induced injury. DALDA, 50 mg/kg, was
administered s.c. to MORf/f and MORIEC/ mice 10
minutes before I/R exposure. Healthy tissues (H)
represent a nonischemic region of the small bowel
adjacent to the damaged area. A: Representative
H&E images of ileal Swiss rolls. N Z 5 to 6 per
group. B: Histological damage scores show DALDA-
mediated protection from I/R injury only in mice
with functional IEC-derived MOR signaling (MORf/f).
N Z 5 to 6 per group. *P < 0.05. C: The TUNEL
assay demonstrates decreased apoptotic/necrotic
IECs in DALDA-treated mice with functional IEC-
derived MOR signaling. Cells with fragmented
DNA are stained green, whereas DAPI counterstain
marked all intestinal cells. Data are representative
of three sections per group, from two different
mice. IHC analysis of activated caspase-3 (Casp-3)
from an ileal section of DALDA-treated MORf/f
and MORIEC/ mice showed decreased caspase-3
staining in mice with functional IEC-derived MOR
signaling. Images are representative of two
different mice. Scale bars: 200 mm (A and B); 100
mm (C). Veh, vehicle.
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Figure 3 The MOR-mediated cytoprotective effect does not correlate
with decreased cytokine production. Mice were treated with DALDA and
exposed to I/R, as described in the legend to Figure 2. Il1b, Il6, and tumor
necrosis factor (Tnf) mRNA ileal tissue levels were determined using an ABI
Prism7900HT. Data were processed using the DDCT method, normalized to
b-actin, and set relative to shameoperated on mouse tissue. No statistical
signiﬁcance was noted between any of the ischemic tissue groups.
P < 0.0317 for Il1b, P < 0.0159 for Il6 for the comparison between the
sham and all ischemic groups. N  3 per group. *P < 0.05.
Goldsmith et alDNeasy Blood and Tissue Kit (Qiagen) was used according to
the manufacturer’s protocol. Isolated DNA was subjected to
real-time PCR, as previously described, using the following
primers: universal 16s rDNA (50-GTGSTGCAYGGYTGTC-
GTCA-30 and 50-ACGTCRTCCMCACCTTCCTC-30), nor-
malized to murine Gapdh (as previously described).
CMT-93 Cell Culture and Stimulation
Murine rectal carcinoma cells (passage 33 to 59) (ATCC,
Manassas, VA) were cultured in Dulbecco’s modiﬁed Eagle’s
medium high glucose, as previously described.27 Cells were
starved overnight in Opti-MEM (Cellgro, Manassas, VA) and
then treatedwith DALDA (10mmol/L) for the times indicated.
MOR signaling was inhibited with the opioid antagonist,
naloxone (Sigma-Aldrich; 10 mmol/L in dimethylsulfoxide),
30 minutes before DALDA exposure. Protein synthesis was
blocked with cycloheximide (Sigma-Aldrich) (50 mg/mL).
Cells were directly lysed in one times Laemmli buffer, and
protein concentration was measured using a Bio-Rad quanti-
ﬁcation assay.
Western Blot Analysis
Proteins (30 mg) were separated using 10% SDS-PAGE,
transferred to nitrocellulose membranes, and then probed
with antibodies speciﬁc to cleaved-caspase-3, p-GSK3b
(Ser9), and p-AKT (Ser473), at a 1:1000 dilution, andGSK3b
and AKT at a 1:2000 dilution (Cell Signaling Technology) in
5% nonfat milk, 2% bovine serum albumin in Tris-buffered
salineeTween (0.1%), and b-actin (1:10,000) (MP Biomed-
ical, Solon, OH), followed by the appropriate horseradish
peroxidaseeconjugated secondary antibody (1:10,000) (GE
Healthcare, Piscataway, NJ). The immune complexes were
detected using chemiluminescence.
Apoptosis Assays
Murine rectal-carcinoma CMT-93 cells were plated to 70%
conﬂuence in 8-well chamber cells (Thermo Scientiﬁc,
Waltham, MA), and exposed to 1 mmol/L staurosporine
(Sigma-Aldrich) for 6 hours concurrently with 10 mmol/L
DALDA and/or 1 mmol/L wortmannin. A ﬂuorometric
TUNEL assay was then performed as previously described,
according to the manufacturer’s protocol.
Statistical Analysis
Unless speciﬁcally noted, statistical analyses were performed
usingGraphPad Prism version 5.0a (GraphPad, La Jolla, CA).
Comparisons of mouse studies were made with a nonpara-
metric, one-way analysis of variance, and a Kruskal-Wallis
test with Dunn’s multiple comparison post test. Further
comparisons made between mice were analyzed using a
U-test at a 95% CI. In vitro migration data and cell counting
were compared with Student t-tests, at a 95%CI. Radioligand780binding assays were analyzed using a nonlinear ﬁt (single-
binding site) function, built into Prism. All graphs depict
means  SEM. Experiments were considered statistically
signiﬁcant if P < 0.05.
Results
Generation of IEC-Speciﬁc, MOR GeneeDeleted Mice
To deﬁne the role of IEC-derived MOR signaling in the
intestine, we crossed ﬂoxed-MORmice (MORf/f) to Villin-Cre
mice to generate IEC-speciﬁc geneedeletedmice (MORIEC/)
(Figure 1A). PCR analysis showed MOR (Oprm1) mRNA
accumulation in puriﬁed IECs and splenocytes from MORf/f
mice, whereas the transcript was absent in the IECs of
MORIEC/ mice (Figure 1B). MOR mRNA accumulation
was detected in splenocytes isolated from MORIEC/ mice,
showing the speciﬁcity of MOR gene deletion (Figure 1B).
Radioligand binding assays revealed a lack of detectable
binding of the MOR-speciﬁc ligand 3H-DAMGO in IEC cells
isolated from MORIEC/ mice compared with MORf/f mice
(Table 1). 3H-DAMGO binding to brain (cortex) cell
membrane extracts was not signiﬁcantly altered inMORIEC/
mice. These ﬁndings conﬁrmed that MOR signaling is func-
tionally ablated in IECs inMORIEC/ mice.
IEC m-Opioid Signaling Protects against I/R Injury
To address the cell typeespeciﬁc role of MOR signaling in
intestinal injury response, we subjected mice to an episode
of I/R-induced injury, in which the peripheral branches ofajp.amjpathol.org - The American Journal of Pathology
IEC-MOR Signaling in Intestinal Injurythe superior mesenteric artery were clamped for 60 minutes
(ischemic phase), followed by 90 minutes of reperfusion. As
shown in Figure 2, I/R-induced injury results in epithelium
denudement, with partial to complete ablation of the crypts,
alongside immune cell inﬁltration into the lamina propria.
Interestingly, the administration of 50 mg/kg DALDA
dramatically reduced I/R-mediated tissue damage compared
with untreated mice, as shown by histological damage
assessment (2.5 versus 0.6; P < 0.05) (Figure 2, A and B).
However, DALDA was unable to protect MORIEC/ mice
from I/R-induced injury compared with MORf/f mice (1.75
versus 2.58; P Z 0.2920) (Figure 2, A and B).
Because of hypoxic conditions, I/R-induced injury leads
to increased IEC apoptosis with associated disruption of
intestinal barrier function.4,5,10 A ﬂuorescent TUNEL assay
showed enhancement of fragmented DNA, indicative of
apoptosis/necrosis in injured mice, which was absent inThe American Journal of Pathology - ajp.amjpathol.orgmice treated with DALDA (Figure 2C). DALDA-mediated
reduction of DNA fragmentation was ablated in MORIEC/
mice (Figure 2C). To speciﬁcally address the role of apoptosis
in DALDA-mediated protection, we investigated the level of
caspase-3 activation using IHC. Interestingly, caspase-3
activation was strongly reduced after DALDA treatment, an
effect abrogated in MORIEC/ mice (Figure 2C). These
ﬁndings indicate that IEC-derived MOR signaling is critical
for the DALDA-mediated protective effect on the epithelium.
Interestingly, I/R-induced Il1b and Il6 mRNA accumu-
lation was not modulated by DALDA administration, nor
was it affected by the status of MOR expression (Figure 3).
A similar, but less robust, pattern of induction was noticed
with tumor necrosis factor mRNA (data not shown).
Because I/R-induced injury is a multiphase process, we next
investigated the role of MOR signaling during the early
ischemic phase of intestinal injury. Administration of DALDAFigure 4 DALDA (DAL) administration protects
against ischemia-induced injury and attenuates bac-
terial translocation. DALDA, 50 mg/kg, was adminis-
tered s.c. to MORf/f and MORIEC/ mice 10 minutes
before ischemia (I) exposure (60 minutes). Healthy
tissues (H) representanonischemic regionof the small
bowel adjacent to the damaged area. A: Representa-
tive H&E images of ileal Swiss rolls. B: Histological
damage scores showDALDA-mediated protection from
ischemia injury only in mice with functional IEC-
derived MOR signaling (MORf/f). N Z 5 to 6 per
group.C: PCR quantiﬁcation of total bacterial 16S DNA
at 4 hours of reperfusion shows that MOR-mediated
protection results in decreased bacterial dissemina-
tion to the liver. Data were analyzed by the DDCT
method, normalized to murine Gapdh, and compared
with control. N Z 4 per group. D: IHC analysis
of activated caspase-3 from an ileal section of
DALDA-treatedMORf/f andMORIEC/mice shows that
enterocyte MOR signaling conﬁrms protection from
apoptosis during the ischemic phase of injury. Images
are representative of three different mice. Scale
bars: 200 mm (A and D). Veh, vehicle. *P < 0.05,
**P < 0.01.
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Figure 5 MOR signaling directly induces GSKb phosphorylation in
a PI3K-dependent manner in CMT-93 cells. CMT-93 cells were stimulated with
10 mmol/L DALDA for the indicated time in the presence or absence of
50 mg/mL cycloheximide or 10 mmol/L MOR inhibitor, naloxone. Proteins
were extracted and subjected to Western blot analysis. A: Kinetic analysis of
Akt and GSK3b phosphorylation. B: DALDA-mediated GSK3b phosphorylation
is unaffected in cycloheximide-treated cells. Data are representative of three
independent experiments. C: DALDA-mediated GSK3b phosphorylation
is abrogated in naloxone-treated cells. Data are representative of three
independent experiments.
Goldsmith et alprotected against the induction of intestinal damage during the
ischemic phase (2.7 versus 1.5; P< 0.01), an effect dependent
on the presence of functional IEC-MOR signaling (Figure 4, A
and B). These data suggest that IEC-derived MOR signaling
protects against the deleterious effect of ischemia.
One potentially serious outcome of intestinal ischemia is
multiorgan dysfunction syndrome,11 which results from bacte-
rial translocation and dissemination after loss of the intestinal
barrier function.13 To assess for the presence of extra-intestinal
bacteria during I/R-induced injury, we measured the bacterial
16S rDNA in the liver. Increased bacterial 16S rDNA
(approximately fourfold) in the liver of I/R-exposed MORf/f
mice was signiﬁcantly decreased in DALDA-treated mice,
whereas this beneﬁcial effect was lost in MORIEC/ mice
(Figure 4C). Theseﬁndings indicate thatDALDAprevented the
initial ischemia-induced insult and halted bacterial translocation
to extra-intestinal organs.
TUNEL (data not shown) and IHC analyses of activated
caspase-3 demonstrated that IEC-MOR signaling conferred
protection during the ischemic phase of injury through up-
regulation of prosurvival/anti-apoptotic signals (Figure 4D).
MOR-Mediated Protection Involves PI3K-Mediated
GSK3b Phosphorylation
We previously showed in vitro that IEC wound-healing
responses are dependent on PI3K/GSK3b signaling.28 To
test the role of the PI3K/GSK3b pathway in the MOR-
mediated protective effect, we stimulated CMT-93 cells with
10 mmol/L DALDA for a variable period and performed
Western blot analysis. DALDA rapidly increased bothAkt and
GSK3b phosphorylation in CMT-93 cells (Figure 5A). Inter-
estingly, the protein synthesis inhibitor, cycloheximide, failed
to blockDALDA-inducedGSK3b phosphorylation, indicating
a direct effect on the PI3K/Akt/GSK3b pathway (Figure 5B).
To better deﬁne the role ofMOR inDALDA-mediatedGSK3b
phosphorylation, we treated CMT-93 cells with 10 mmol/L of
the opioid antagonist, naloxone.22 DALDA-induced GSK3b
phosphorylation was blocked in naloxone-exposed cells
compared with control, highlighting the key role of MOR in
this process (Figure 5C).Altogether, theseﬁndings suggest that
DALDA signals through MOR to activate the PI3K/GSK3b
pathway without the need of de novo protein synthesis.
Because cellular apoptosis is a key event in I/R-induced
intestinal injury, we determined the impact of DALDA and
PI3K/GSK3b signaling on staurosporine-induced CMT-93
cell apoptosis. The TUNEL assay shows that DALDA medi-
ated blockade of staurosporine-induced apoptosis in CMT-93
cells is attenuated following exposure to 1 mmol/L wortmannin
(Figure 6A). Similarly, DALDA-mediated blockade of
caspase-3 processing was reversed in wortmannin-treated
CMT-93 cells (Figure 6B). Together, these ﬁndings indicate
that PI3K activation is necessary for a DALDA-mediated anti-
apoptotic effect.
To expand these observations in vivo, we performed IHC
analysis on DALDA-treated mice. Interestingly, IEC-speciﬁc782Akt and GSK3b phosphorylation is enhanced in DALDA-
treated MORf/f mice compared with the vehicle-treated mice
(Figure 7, A and B). We further quantiﬁed p-GSK3b staining
and found increased staining in the crypts of DALDA-treated
MORf/f mice compared with the vehicle-treated mice (7.2
versus 3.9; P < 0.01) (Figure 7C). Finally, we observed that
activation of these signaling pathways was abrogated in
DALDA-treated MORIEC/ mice (Figure 7, AeC), demo-
nstrating that these effects were a result of direct enterocyte-
mediated MOR signaling.
To determine the functional role of PI3K signaling in the
DALDA-mediated protective effect,MORf/fmice were treated
with 0.25 mg/kg, i.p., of the PI3K inhibitor, Ly294002. Inter-
estingly, the DALDA-mediated protective effect against I/R-
induced injury was lost in mice treated with Ly294002
(Figure 8, A and B). In addition, the administration of
Ly294002 resulted in decreased DALDA-mediated induction
of GSK3b phosphorylation and reduction in baseline GSK3b
phosphorylation levels (Figure 8, C and D). Furthermore,
DALDA-mediated blockade of caspase-3 processing in injured
tissue was reversed after exposure to Ly294002, indicating the
key role of IEC-derived PI3K signaling in the cytoprotective
effects of DALDA (Figure 8E).Discussion
Intestinal ischemia/reperfusion injury is a serious pathological
condition with a potentially lethal sequel, including multipleajp.amjpathol.org - The American Journal of Pathology
Figure 7 DALDA-induced protection from I/R injury correlates with
enterocyte AKT and GSK3b phosphorylation. Mice were treated with DALDA
and exposed to I/R, as described in the legend to Figure 2. Healthy tissues
(H) represent a nonischemic region of the small bowel adjacent to the
damaged area. A: Representative IHC of ileal Swiss rolls stained for p-Akt.
N Z 2 per group. B: Representative IHC of ileal Swiss rolls stained for
p-GSK3b. N Z 3 per group. C: Number of p-GSK3bepositive crypts per
10 crypts. N Z 3 mice per group, with three random ﬁelds of view per
mouse. Analysis was performed by one-way analysis of variance with
Tukey’s post test. **P < 0.01. Scale bars: 200 mm (A and B).
Figure 6 DALDA-induced protection from apoptosis is PI3K dependent.
CMT-93 cells were exposed to 1 mmol/L staurosporine for 6 hours in the
presence or absence of 10 mmol/L DALDA and/or 1 mmol/L wortmannin
(Wort). A: Apoptosis was detected by TUNEL staining. Cells were also
stained with DAPI as a control. Representative images of three independent
experiments are shown. B: DALDA prevents staurosporine-induced caspase-3
processing in CMT-93 cells. Cells were treated as previously described, and
proteins were extracted and subjected to caspase-3 Western blot analysis.
Actin was used as a loading control. Representative data of three inde-
pendent experiments are shown. FITC, ﬂuorescein isothiocyanate.
IEC-MOR Signaling in Intestinal Injuryorgan dysfunction syndrome.11 Unfortunately, no therapeutic
strategies are available to treat the underlying intestinal injury
that drives many of these sequels. Although opioid agonists
have been shown to protect various organs against injury,The American Journal of Pathology - ajp.amjpathol.orgincluding the intestine and heart, the cellular compartment(s)
mediating these effects have remained elusive. Because IEC
responses to various injuries, including inﬂammation, radia-
tion, and I/R, are critical for the maintenance of intestinal
barrier function,13,29e31we speculated that these cells drive the
DALDA-mediated protective effect. Indeed, selective genetic
removal of MOR signaling in IECs abrogated the cytopro-
tective action of DALDA after I/R exposure. Because the
extent of intestinal injury after I/R-induced injury is similar
betweenMORf/f andMORIEC/mice,we conclude thatMOR
signaling is protective only in the presence of an exogenous
ligand (eg, DALDA). In addition, adjacent healthy tissue
showed no alterations in villus length or crypt numbers in
MORIEC/mice. Furthermore, the administration ofDALDA
did not result in increased villus length or crypt numbers in the
healthy tissue of MORf/f mice. These ﬁndings suggest that
DALDA/MOR-mediated protection is a direct result of tightly
regulated MOR signaling that occurs only in injured tissue.783
Figure 8 DALDA-mediated cytoprotection is
PI3K dependent. The PI3K inhibitor, Ly294002
(Ly), was administered to MORf/f and MORIEC/
mice at 0.25 mg/kg, i.p., 10 minutes before
injection of vehicle or DALDA and then exposed to
I/R, as described in the legend to Figure 2.
Histological characteristics (A) and histological
damage scores (B) show that DALDA-mediated
protection from I/R injury requires functional
PI3K signaling. N Z 4 to 11 per group. C and D:
DALDA-induced p-GSK3b phosphorylation is ablated
in mice treated with Ly294002. Scale barZ 200 mm.
Positive staining p-GSK3b crypts per 10 total
crypts. Results are from ﬁve to six mice per group,
with two random ﬁelds of view per mouse. Analysis
was performed by one-way analysis of variance
with Tukey’s post test. E: IHC for activated
caspase-3 (Casp-3) shows that DALDA-mediated
apoptosis prevention is PI3K dependent. Repre-
sentative images from four mice per group are
shown. Scale bars: 200 mm (A and C); 100 mm (E).
*P < 0.05, ***P < 0.001. DMSO, dimethylsulf-
oxide.
Goldsmith et alInterestingly, DALDA administration had no signiﬁcant
modulatory effect on I/R-induced Il6, Il1b, and tumor necrosis
factor mRNA expression levels. Because MORIEC/ mice
have functional MOR in the immune compartment, these
ﬁndings suggest that DALDA/MOR primary therapeutic
effects are not immune cell mediated. Also, this suggests that
the induction of inﬂammatory cytokines in the intestine in the
early stages of I/R-induced injury is driven by the presence of
hypoxic conditions more than the extent of injury to the tissue
itself. This is compatible with the reported effect of hypoxia
on inﬂammatory gene expression observed in the intestine
and may represent an adaptive response to promote resistance
to apoptosis in IECs.32,33
We observed the protective effect of DALDA in the
ischemic phase of injury, duringwhich IECs typically undergo
apoptosis because of prolonged hypoxia,4,5,10 suggesting that
anti-apoptosis may be the primary mechanism of protection
conferred by DALDA. Previous reports showed that MOR
activates the proproliferative and survival signaling pathway
PI3K/Akt/GSK3b in numerous in vitro systems18 and during
cardiac ischemia.15Herein, we showed that DALDA enhanced
AKT and GSK3b phosphorylation in the intestine in vivo,
which correlated with protection from intestinal ischemia. The
pharmacological agent, Ly294002, demonstrated that MOR-
mediated protection from I/R injury requires activation of
PI3K signaling.We conﬁrmed these ﬁndings in vitro, showing
that DALDA/MOR signaling directly activates the PI3K/Akt/
GSK3bpathway.Furthermore,TUNELandactivatedcaspase-3
analysis showed that wortmannin reverses the DALDA-
mediated protection against staurosporine-induced apoptosis.784The anti-apoptotic role of the PI3K signaling pathway has
been observed in enterocytes,34 and in endothelial cells sub-
jected to hypoxic conditions.35 Downstream, phospholipid-
dependent Akt pathway activation has been implicated in
the anti-apoptotic effects of PI3K activation.19 Akt activation
can lead to enhancement of prosurvival signaling through
IkB kinaseemediated increases in NF-kB activity.19 Akt
activation can also directly inhibit apoptotic signals, such as
Fas-L, Bax, and p53, and promotes anti-apoptotic signals,
such as Bcl-XL and Bcl-2.19 In addition, Akt activation results
in GSK3b phosphorylation, leading to inhibition of apoptotic
signals mediated by MCL-1 and Bax and enhancement of
prosurvival signals, such as b-catenin.19 Because DALDA
failed to directly activate NF-kB signaling in IECs14 and
competitive inhibition of MOR abrogates GSK3b phos-
phorylation, the PI3K/Akt/GSK3b pathway is likely
responsible for the anti-apoptotic effects of the opioid.
The functional impact of DALDA-mediated intestinal
barrier enhancement through PI3K activity includes the
prevention of microbial translocation. The presence of
bacterial 16S rDNA in the liver of I/R-exposed mice was
strongly decreased by DALDA administration. This is an
important ﬁnding, because bacterial translocation across
a damaged barrier is the main source of multiorgan failure in
patients experiencing intestinal ischemia.4,5,11
Overall, these studies demonstrate, for the ﬁrst time to our
knowledge, that activation of IEC-speciﬁc, PI3K-dependent
MOR signaling resulted in protection from ischemia/
reperfusion-induced intestinal injury. The lack of therapies
for treating intestinal ischemia, combined with the wideajp.amjpathol.org - The American Journal of Pathology
IEC-MOR Signaling in Intestinal Injuryavailability of Food and Drug Administrationeapproved,
MOR-speciﬁc agonists to clinicians, makes this work of
particular clinical relevance.
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